Kiora Pharma appoints Praveen Tyle as Chairman; Paul Chaney retires after 17 years

KIORA PHARMACEUTICALS INC

Paul Chaney resigned as Chairman and Board member effective Sept 20, 2023; no disagreement cited.
Praveen Tyle, PhD, appointed Chairman effective same date; also serves as director.
Erin Parsons appointed Chair of Compensation Committee; Carmine Stengone joins Audit and Nominating Committees.
Tyle to help guide development of KIO-301 for retinitis pigmentosa and other inherited retinal diseases.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Paul Chaney

Chairman

KPRX · KIORA PHARMACEUTICALS INC

Effective: 2023-09-20
Successor: Praveen Tyle
Filed: September 21, 2023, 7:59 PM ET

On September 20, 2023 (the “Effective Date”), Paul Chaney resigned as Chairman and member of the Board of Directors (the “Board”) of Kiora Pharmaceuticals, Inc. (the “Company”) from the Audit Committee and Nominating and Corporate Governance Committee of the Board, effective as of the Effective Date.

Appointed

Praveen Tyle

Chairman

KPRX · KIORA PHARMACEUTICALS INC

Effective: 2023-09-20
Filed: September 21, 2023, 7:59 PM ET

the Board appointed Praveen Tyle, Ph.D. as Chairman of the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Paul Chaney resigned as Chairman at KIORA PHARMACEUTICALS INC.

Action: resigned
Role: Chairman

Exact text from the filing

On September 20, 2023 (the “Effective Date”), Paul Chaney resigned as Chairman and member of the Board of Directors (the “Board”) of Kiora Pharmaceuticals, Inc. (the “Company”) from the Audit Committee and Nominating and Corporate Governance Committee of the Board, effective as of the Effective Date.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Praveen Tyle was appointed as Chairman at KIORA PHARMACEUTICALS INC.

Action: appointed
Role: Chairman

Exact text from the filing

the Board appointed Praveen Tyle, Ph.D. as Chairman of the Board.

View on SEC.gov

KIORA PHARMACEUTICALS INC filing history →

Source: SEC EDGAR

accession 0001372514-23-000129

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.